“(D/pf). . ‘W‘ﬁ (Wham aim/5
67%;: W was (550:?

“m ‘fs/le I795“! Ar ﬁr

CLINICAL HISTORY:
Right breast FNA negative. 2 x 1.5 cm tumor. Oriented by Dr.
grossly.

SuqlPaﬂl

GROSS EXAMINATION:

A. ”Right breast biopsy", in formalin. The specimen consists of a 6.0 x 3.8 x
2.8 cm sample of firm, yellow—white, fibroadipose tissue that is received
previously incised. The specimen was oriented grosely by Dr. , and the
lateral operative margin inked in blue, medial operative margin inked in
black, and the anterior operative margin inked in red. The specimen is
sectioned superiorly to inferiorly revealing a firm, white scuirrious uniform
lesion with irregular borders extending up to 2 cm in greatest dimension. The
lesion abuts the medial and inferior operative margins. The specimen is
submitted in toto in Blocks Al—A13 from inferior to superior and anterior to
posterior.

Also received is a sample of firm, yellow-white fibroadipose tissue measuring
4.3 x 4.0 x 1.3 cm in size. The sample is oriented by Dr. ; and the new
surgical margin is inked in blue and the old surgical margin is inked in
black. The new surgical margin represents the true margins. Serial
sectioning reveals a firm, white, infiltrative lesion extending through much
of the specimen and abutting the blue inked surgical margin. Submitted in
toto in Blocks Al4—A20. ' ".Ib4w’

    
 

Samples of the lesion were obtained for ER/PR studies.
Dr.

DIAGNOSIS:
A. "RIGHT BREAST BIOPSY" (EXCISIONAL BIOPSY):

  

.‘ 96(11§5 an+n cussrc
INFILTRATING CARCINOMA PRESENT, HISTOLOGIC TYPE, DUCTAL.’ ‘Tcevﬂ—fvnnof is cvuadruvnn
. . . .P. HISTOLOGIC GRADE 2 or 3. “““
N.S.A.B.P. NUCLEAR GRADE, 2'03 3. "um:g‘m‘gg'IFg'“§ﬁ'%B:"“°3WD§“d
GROSS TUMOR SIZE, 2 cm. " CGA' ' 99' ' e a

cted
sun or mvmvs coupoum 2 cu. ll Illlllllllllllllllll IIlllllllllllllllll|||||||||l|||||||
' II I I ll ll||||||||||||||Illllllllllllll

I
DUCTAL IN-SITU CARCINOMA, EXTENSIVE. I I IHHHIIHHII
MULTIFOCAL TUMOR NO.
o. m mam mm... W um |IIllI||||||||||||IIlllllllllllllIllllllllllllllllllll
SIZE OF IN SITU CARCINOMA, 2 CM.

STATUS OF NON-NEOPLASTIC BREAST TISSUE, APOCRINE METAPLASIA AND DUCT
ECTASIA.

LYMPHATIC/VASCULAR INVASION, NOT PRESENT.
SURGICAL HARGIN STATUS, NEGATIVE.
MICROCALCIFICATIONS NOT PRESENT.

ESTROGEN/PROGESTERONE AND CELL CYCLE ANALYSIS PENDING, YES.
METHODOLOGY, FRESH TISSUE. SEE NOTE.
RESULTS WILL BE ISSUED IN AN ADDENDUM.

NOTE: The original biopsy specimen shows carcinoma in situ to both lateral
and medial margins. The reexcision specimen shows operative margins to be
free of malignancy. This specimen shows a singlewsmgll focus of residual
invasive carcinoma, inﬁiltratinggdugtal”type) N.S.A.B.P. histologic grade 2,
nuclear grade 2, and residual_iﬁtzaguct§;:§§rcinoma of non§CCmedo type. Breast
tissue away from the carcinoma in this specimEEwEHSws blunt duct adenosis and'”
a small radial scar.

M

Verified by: . Pager#
Date Signed:

ADDENDUM 1:
Tissue was sent to the for assay of the Estrogen
and Progesterone receptors. The Estrogen receptor was judged as positive with
an estimated fmol valve of 166. The Progesterone receptor was judged as
positive with an estimated fmol valve of 11. Please report to I for
more complete details.
Verified by: ‘ --‘ Pager
Date Signed:

20f2

 

 

 

TCGA Pathologlc Diagnosis Discrepancy Form

V4.00

 

 

 

 

 

W The TCGA Pathologic Diagnosis. Discrepancy Farm should be. carhpleted when the pothole.

documented on the Initial pathology mphrtfar a case submitted for TCGA Is' incmwlstent with the diagnosis provided on the I
(3639: Quality Control- Form completed for the submitted case. ’ . . , , . . , . . . ’

 

' diagnosis

   

  

 

 

 

 

 

 

 

 

 

 

 

 

 

Tissue Source Site {’I’SS): __ TSS‘ Identiﬁer. . TSS-Unlqse Patient Identiﬁed
Completed By (Inmlewerﬂame on . Completed Date:
lbnwgss'mfmhanon;.Ii;,igi ,. A :7, ., ~ ~ ..
It Data Element Brigg-Alternatives Working Instructions
Prmrlds the diagnosis] bls'tologic sunﬁsh) Walled on
Pathologic- Diagnosis ‘ 0:" t e initial pullolomr report for this use. If the himluw for
1 Provided on I nltial m s: i; missed. provide all listed submits.
Pathology Report Wad-3m
. V Pfovtdc the histologir'feamrés selected on the TCGA Case
Hlstolaglc ream?” If . Quality Canto! Form mainland for misuse.
2 the sample prowded
for TCGA. as reﬂected
' on the CQEE. p
_1 mm ’ " pant)! berm npaehmmnmriauai nationality calibrating 1355. A;

 

 

 

 

 

 

 

3 Provide the reason for Provide a reason describing why the diagnosis on m: initial
~ . . . , pamolngy report fol-this ms: is not consistent with the
the discrepancy . 5&MP‘Q S Wbm *H'eex diagnosis selected on the 'l‘CGA Case (inlay Control Farm.
between thepatholsgy \
_ report and the TCGA ~ , - V V
_ Case Quality Control (“Q/V l-{UJHQ (S W“ \C 4r ‘ {a
Fm“ chigutd Jenn): \ \
Q‘s-x m ﬁrst we -
V Name of'TSS Reviewing Provide the Mm of the vamoiozlst who rmwcd ibis ma
4 Fathologist or MEGA
Biomposlmry Director

 

 

 

I acknowledge that the strove Infannatlan pmvided by my Institution is m and con-art and has been qualms controlled.

 

T55 Reviewing Pathologist or Biompositnry Director

Date

I acknowlcdgy that the above Information provided by. my Inmmdun f; true and com and has been quality continued nemmmg Pamamgm cf the
minimum Chairman has been Informed or is aware ofthe am dismpsncy In magnum

'lgnnclpal Investigator Signature

Date

